BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17919347)

  • 1. Ductal carcinoma in situ: biology, diagnosis, and new therapies.
    Valenzuela M; Julian TB
    Clin Breast Cancer; 2007 Aug; 7(9):676-81. PubMed ID: 17919347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
    Gangi A; Topham A; Lee MC; Sun W; Laronga C
    South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Trends in the Management of Ductal Carcinoma In Situ.
    Park TS; Hwang ES
    Oncology (Williston Park); 2016 Sep; 30(9):823-31. PubMed ID: 27633413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH; Farley DR; Peros G
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ductal carcinoma in situ].
    Skaar M; Langhans L; Mertz B; Kroman N
    Ugeskr Laeger; 2018 Sep; 180(38):. PubMed ID: 30259839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.